Vancouver Coastal Health

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

123I-meta-iodobenzylguanidine · Oncology; Nuclear Medicine; Endocrinology
123I-meta-iodobenzylguanidine is a radiolabeled imaging agent that accumulates in neuroendocrine tumors and the sympathetic nervous system, allowing visualization via nuclear scintigraphy.

Phase 1 pipeline

Mycobacteriophage Muddy_HRMN0052

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Vancouver Coastal Health portfolio CI brief
Vancouver Coastal Health pipeline updates RSS

Frequently asked questions about Vancouver Coastal Health

What is Vancouver Coastal Health's pipeline?

Vancouver Coastal Health has 1 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include 123I-meta-iodobenzylguanidine.

Sector hub: All tracked pharma companies